- Zacks•4 days ago
Keryx Biopharmaceuticals, Inc. (KERX) announced that the nation's largest Medicare Part D plan sponsor has added Auryxia (ferric citrate) to its Medicare Part D plan formularies.
- Accesswire•5 days ago
NEW YORK, NY / ACCESSWIRE / March 21, 2017 / The current word from market observers is that the biotech sector may have new life breathed into it by a Republican led Congress and the new administration. ...
- GlobeNewswire•6 days ago
Keryx Announces the Largest Medicare Part D Plan Sponsor Added Auryxia® to its Medicare Part D Plan Formularies
BOSTON, March 20, 2017-- Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today announced that the nation’ s largest Medicare ...
KERX : Summary for Keryx Biopharmaceuticals, Inc. - Yahoo Finance
Keryx Biopharmaceuticals, Inc. (KERX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||4.00 x 30200|
|Ask||12.17 x 100|
|Day's Range||5.46 - 5.71|
|52 Week Range||4.03 - 7.80|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-3.71|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|